Phio Pharmaceuticals Corp. Banner Image

Phio Pharmaceuticals Corp.

  • Ticker PHIO
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Phio Pharmaceuticals Corp. Logo Image
  • 11-50 Employees
  • Based in Marlborough, Massachusetts
Phio Pharmaceuticals Corp. (Nasdaq: PHIO) is a biotechnology company developing the next generation of immuno-oncology therapeutics based on its self-delivering RNAi (INTASYLâ„¢) therapeutic platform. The Company's efforts are focused on silencing tumor-induced suppression of the immune system through its proprietary INTASYL platform with utility in immune cells and the tumor micro-environmentMore. Their goal is to develop powerful INTASYL therapeutic compounds that can weaponize immune effector cells to overcome tumor immune escape, thereby providing patients a powerful new treatment option that goes beyond current treatment modalities.
Phio Pharmaceuticals Corp.

Most Recent Annual Report

Phio Pharmaceuticals Corp.
MOST RECENT 2021 Form 10K

Older/Archived Annual Reports